Below is the 2021 schedule and agenda for the BIO CEO & Investor Conference.

BIO CEO & Investor Digital Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO CEO & Investor Digital Conference
Jump to Day
12 Results
Available On-Demand
Adjuvance Technologies is a privately held biopharmaceutical company dedicated to empowering health…
AGT, has a broad viral vector delivery platform evolved over ten years of advanced development. AGT…
Citranvi Biosciences is a preclinical stage company led by a seasoned leadership team with…
Clarametyx Biosciences is building a transformative biologic platform for biofilm-associated…
Evrys Bio was founded on breakthrough discoveries from Princeton University. Whereas immuno…
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against…
Ichor Biologics is a New York City based, pre-clinical biotechnology company that has generated a…
SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help…
Stadius Biopharma is an early stage biopharma company working to deliver novel, transformational…
Venatorx Pharmaceuticals is a private pharmaceutical company focused on improving health outcomes…
Virion is developing novel T cell-based immunotherapies for cancer and infectious diseases via a…
Virios Therapeutics, Inc. (Nasdaq: VIRI) is a biotechnology company focused on advancing novel…